Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Accumulated Depreciation & Amortization: 2011-2018

  • EyePoint Pharmaceuticals' Accumulated Depreciation & Amortization was N/A to $695,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $3.5 million, marking a year-over-year change of. This contributed to the annual value of $653,000 for FY2018, which is 34.36% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Accumulated Depreciation & Amortization of $695,000 as of Q4 2018, which was up 6.43% from $653,000 recorded in Q2 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $1.9 million in Q2 2014 and a low of $486,000 during Q2 2017.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $674,000 (2018), whereas its average is $881,750.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first crashed by 71.29% in 2017, then spiked by 34.36% in 2018.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Accumulated Depreciation & Amortization stood at $1.9 million in 2014, then decreased by 4.44% to $1.8 million in 2015, then declined by 6.26% to $1.7 million in 2016, then plummeted by 71.29% to $486,000 in 2017, then soared by 34.36% to $695,000 in 2018.
  • Its last three reported values are $695,000 in Q4 2018, $653,000 for Q2 2018, and $486,000 during Q2 2017.